Nucleic acid sensing as a driver of tumour immunogenicity

Date 29 September 2019
Event ESMO 2019 Congress
Session DNA damage response modification as a therapeutic strategy in head and neck cancer
Topics Basic Scientific Principles
Clinical Research
Biological Therapy
Tumour Immunology
Immunotherapy
Cancer Biology
Radiation Oncology
Head and Neck Cancers
Presenter Kevin Harrington
Authors K.J. Harrington
  • Radiotherapy & Imaging, Institute of Cancer Research ICR, SW3 6JB - London/GB